Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

JOHNSON, Neb. (KOLN ... Over the past 2 years, the Eagles have won 50 straight games including back-to-back state titles. “I never could have imagined the 50 straight wins or anything like ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Less than 48 hours after their season came to an end, the Lions lost again. On Monday, Ben Johnson decided to leave his post as Detroit's offensive coordinator. He will reportedly stay in the NFC ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...